TGFB1 and breast cancer: Considering the deleterious effect of metastases on BC patients’ survival, our data might strengthen the interest in assessing CAF subsets content in LN for clinical diagnosis and in using anti-TGFβ and/or anti-NOTCH therapies in BC.